| Signature-based approaches for informed drug repurposing: targeting CNS disorders R Shukla, ND Henkel, K Alganem, A Hamoud, J Reigle, RS Alnafisah, ... Neuropsychopharmacology 46 (1), 116-130, 2021 | 53 | 2021 |
| Role of astrocytes in major neuropsychiatric disorders X Zhang, RS Alnafisah, ARA Hamoud, R Shukla, Z Wen, ... Neurochemical research, 1-16, 2021 | 32 | 2021 |
| Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach SM O’Donovan, A Imami, H Eby, ND Henkel, JF Creeden, S Asah, ... Scientific reports 11 (1), 4495, 2021 | 27 | 2021 |
| Bax/tubulin/epithelial-mesenchymal pathways determine the efficacy of silybin analog HM015k in colorectal cancer cell growth and metastasis H Amawi, NA Hussein, CR Ashby Jr, R Alnafisah, LM Sanglard, ... Frontiers in pharmacology 9, 520, 2018 | 19 | 2018 |
| In–vitro activity of Desmostachya bipinnata (L.) Stapf successive extracts against Helicobacter pylori clinical isolates NH Ibrahim, AS Awaad, RA Alnafisah, SI Alqasoumi, RM El-Meligy, ... Saudi pharmaceutical journal 26 (4), 535-540, 2018 | 18 | 2018 |
| Astrocytes in neuropsychiatric disorders: a review of postmortem evidence X Zhang, RS Alnafisah, ARA Hamoud, R Shukla, RE McCullumsmith, ... Astrocytes in Psychiatric Disorders, 153-172, 2021 | 11 | 2021 |
| Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study RS Alnafisah, J Reigle, MA Eladawi, SM O’Donovan, AJ Funk, J Meller, ... Neuropsychopharmacology 47 (12), 2033-2041, 2022 | 10 | 2022 |
| Gene enrichment analysis of astrocyte subtypes in psychiatric disorders and psychotropic medication datasets X Zhang, A Wolfinger, X Wu, R Alnafisah, A Imami, A Hamoud, A Lundh, ... Cells 11 (20), 3315, 2022 | 7 | 2022 |
| Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS SM O’Donovan, H Eby, ND Henkel, J Creeden, A Imami, S Asah, X Zhang, ... Research Square, 2020 | 7 | 2020 |
| Altered purinergic receptor expression in the frontal cortex in schizophrenia R Alnafisah, A Lundh, SM Asah, J Hoeflinger, A Wolfinger, A Hamoud, ... Schizophrenia 8 (1), 96, 2022 | 6 | 2022 |
| Region-specific PSD-95 interactomes contribute to functional diversity of excitatory synapses in human brain AJ Funk, G Labilloy, J Reigle, R Alnafisah, MR Heaven, RC Roberts, ... bioRxiv, 2020.05. 04.076844, 2020 | 2 | 2020 |
| Integrative omics for informed drug repurposing: Targeting CNS disorders R Shukla, ND Henkel, K Alganem, A Hamoud, J Reigle, RS Alnafisah, ... BioRxiv, 2020.04. 24.060392, 2020 | 2 | 2020 |
| Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets. Cells 2022, 11, 3315 X Zhang, A Wolfinger, X Wu, R Alnafisah, A Imami, A Hamoud, A Lundh, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Altered Kinase Networks in Major Depressive Disorder R Alnafisah The University of Toledo, 2023 | | 2023 |
| P307. Dysregulated Kinase Networks in Major Depressive Disorder R Alnafisah, K Alganem, A Hamoud, AS Imami, J Creeden, W Rayn, ... Biological Psychiatry 91 (9), S211-S212, 2022 | | 2022 |
| A Multi-Omics Approach to Understanding ATP Utilization Deficits in Major Depression S O'Donovan, X Wu, J Reigle, R Alnafisah, K Alganem, A Joyce, ... NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 246-246, 2021 | | 2021 |
| Pharmacological impacts on schizophrenia functional analysis: a postmortem proteome study RS Alnafisah, J Reigle, SM O’Donovan, AJ Funk, J Meller, ... bioRxiv, 2021.10. 26.465949, 2021 | | 2021 |
| Signature-based Approaches for Informed Drug Repurposing: Targeting CNS Disorders J Reigle, RS Alnafisah, HM Eby, AS Imami, J Creeden, SA Miruzzi | | 2020 |
| Novel sylibin analogues target ovarian cancer EMT-Wnt/β-catenin resistance pathways HA Amawi, N Hussein, A Fetcenkoa, R Alnafisah, K Chandrabose, ... Cancer Research 77 (13_Supplement), 2238-2238, 2017 | | 2017 |
| Supplementary Information Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS SM O’Donovan, H Eby, ND Henkel, J Creeden, A Imami, S Asah, X Zhang, ... | | |
